First Foundation Advisors Eli Lilly & CO Transaction History

First Foundation Advisors

$2.56 Billion
Q2 2024

A detailed history of First Foundation Advisors transactions in Eli Lilly & CO stock. As of the latest transaction made, First Foundation Advisors holds 2,785 shares of LLY stock, worth $2.44 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

2,785

Previous 2,728 2.09%

Holding current value

$2.44 Million

Previous $2.12 Million 18.8%

% of portfolio

0.1%

Previous 0.09%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	BUY	$724.87 - $909.04 $41,317 - $51,815	57 Added 2.09%	2,785 $2.52 Million
Q1 2024 May 09, 2024	SELL	$592.2 - $792.28 $27,833 - $37,237	-47 Reduced 1.69%	2,728 $2.12 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $966,349 - $1.14 Million	-1,840 Reduced 39.87%	2,775 $1.62 Million
Q3 2023 Nov 15, 2023	BUY	$434.7 - $599.3 $113,891 - $157,016	262 Added 6.02%	4,615 $2.48 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $274,278 - $366,742	782 Added 21.9%	4,353 $2.04 Million
Q1 2023 May 12, 2023	SELL	$310.63 - $364.82 $64,611 - $75,882	-208 Reduced 5.5%	3,571 $1.23 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $76,207 - $88,796	-237 Reduced 5.9%	3,779 $1.38 Million
Q3 2022 Nov 10, 2022	BUY	$296.48 - $337.87 $24,014 - $27,367	81 Added 2.06%	4,016 $1.3 Million
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $16,723 - $19,636	-60 Reduced 1.5%	3,935 $1.28 Million
Q1 2022 May 05, 2022	BUY	$234.69 - $291.66 $76,978 - $95,664	328 Added 8.94%	3,995 $1.14 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $180,779 - $224,348	804 Added 28.08%	3,667 $1.01 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $160,881 - $197,987	726 Added 33.97%	2,863 $662,000
Q2 2021 Aug 13, 2021	SELL	$180.55 - $233.54 $7,763 - $10,042	-43 Reduced 1.97%	2,137 $491,000
Q1 2021 May 18, 2021	BUY	$164.32 - $212.72 $74,272 - $96,149	452 Added 26.16%	2,180 $407,000
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $20,873 - $27,620	160 Added 10.2%	1,728 $292,000
Q3 2020 Nov 12, 2020	SELL	$146.22 - $169.13 $7,457 - $8,625	-51 Reduced 3.15%	1,568 $232,000
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $220,863 - $265,807	1,619 New	1,619 $266,000
Q3 2019 Nov 12, 2019	SELL	$106.79 - $116.16 $319,302 - $347,318	-2,990 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $53,068 - $61,944	-479 Reduced 13.81%	2,990 $331,000
Q1 2019 May 13, 2019	BUY	$111.31 - $131.02 $43,410 - $51,097	390 Added 12.67%	3,469 $450,000
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $6,777 - $7,592	64 Added 2.12%	3,079 $356,000
Q3 2018 Nov 13, 2018	SELL	$85.86 - $107.31 $24,470 - $30,583	-285 Reduced 8.64%	3,015 $324,000
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $41,635 - $47,784	-550 Reduced 14.29%	3,300 $282,000
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $109,830 - $129,647	-1,480 Reduced 27.77%	3,850 $298,000
Q3 2017 Nov 14, 2017	SELL	$77.07 - $85.54 $115,913 - $128,652	-1,504 Reduced 22.01%	5,330 $456,000
Q2 2017 Aug 14, 2017	BUY	N/A	6,834	6,834 $562,000

Others Institutions Holding LLY

# of Institutions

3,872

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $834B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Foundation Advisors, based on Form 13F filings with the SEC.

News

Stay updated on First Foundation Advisors with notifications on news.

Account

First Foundation Advisors Eli Lilly & CO Transaction History